Daqing Huake transferred 15 million new drug technology of wuhudan capsule to Yangzijiang pharmaceutical
-
Last Update: 2020-04-03
-
Source: Internet
-
Author: User
Search more information of high quality chemicals, good prices and reliable suppliers, visit
www.echemi.com
Daqing Huake Co., Ltd announced in the evening of March 22 that the company signed the "new drug technology transfer contract" with Beijing Haiyan Pharmaceutical Co., Ltd of Yangtze River Pharmaceutical Group on March 18, 2013, with the contract technology transfer fee of 15 million yuan The 8th interim meeting of the board of directors in 2012 has considered and passed the proposal on transfer of new drug technology related to wuhudan capsules The pharmaceutical branch of Daqing Huake Co., Ltd was established on November 9, 2000, with a total investment of 115 million yuan, covering an area of 78899m2 and a greening area of 29881m2 (accounting for 38% of the total area) The overall project was completed in January 2002, and passed the national GMP acceptance once on June 19, 2002, and successfully obtained the GMP certificate.
This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only.
This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of
the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed
description of the concern or complaint, to
service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content
will be removed immediately.
